Intratumoral therapies and in-situ vaccination for melanoma
Skin cancers are among the most physically accessible malignancies, so local delivery of a medication into the tumor, so-called intratumoral therapy, is an appealing route of drug administration. Intratumoral therapies have the potential to increase local drug concentration and/or attract immune cel...
Saved in:
Main Authors: | Laura A. Huppert (Author), Adil I. Daud (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
by: Gi Ru Shin, et al.
Published: (2021) -
Systemic and intratumoral 9-valent human papillomavirus vaccine treatment for squamous cell carcinoma in situ in a renal transplant recipient
by: Anna J. Nichols, MD, PhD, et al.
Published: (2020) -
N-Butyl-2-cyanoacrylate-based injectable and in situ-forming implants for efficient intratumoral chemotherapy
by: Yanpu Wu, et al.
Published: (2017) -
Melanoma "in situ" tratado con Imiquimod Melanoma in situ treated with Imiquimod
by: RE Achenbach, et al.
Published: (2012) -
Development of Intratumoral Drug Delivery Based Strategies for Antitumor Therapy
by: Jiang Z, et al.
Published: (2024)